HNRNPK is retained in the cytoplasm by Keratin 19 to stabilize target mRNAs

dc.contributor.authorFallatah, Arwa
dc.contributor.authorAnastasakis, Dimitrios G.
dc.contributor.authorManzourolajdad, Amirhossein
dc.contributor.authorSharma, Pooja
dc.contributor.authorWang, Xiantao
dc.contributor.authorJacob, Alexis
dc.contributor.authorAlsharif, Sarah
dc.contributor.authorElgerbi, Ahmed
dc.contributor.authorCoulombe, Pierre A.
dc.contributor.authorHafner, Markus
dc.contributor.authorChung, Byung Min
dc.contributor.departmentBioHealth Informatics, School of Informatics and Computingen_US
dc.date.accessioned2023-03-03T21:09:55Z
dc.date.available2023-03-03T21:09:55Z
dc.date.issued2022
dc.description.abstractHeterogeneous nuclear ribonucleoprotein K (HNRNPK) regulates pre-mRNA processing and long non-coding RNA localization in the nucleus. It was previously shown that shuttling of HNRNPK to the cytoplasm promotes cell proliferation and cancer metastasis. However, the mechanism of HNRNPK cytoplasmic localization, its cytoplasmic RNA ligands, and impact on posttranscriptional gene regulation remain uncharacterized. Here we show that the intermediate filament protein Keratin 19 (K19) directly interacts with HNRNPK and sequesters it in the cytoplasm. Correspondingly, in K19 knockout breast cancer cells, HNRNPK does not localize in the cytoplasm, resulting in reduced cell proliferation. We mapped cytoplasmic HNRNPK target mRNAs using PAR-CLIP where transcriptome data to show that, in the cytoplasm, HNRNPK stabilizes target mRNAs bound to the 3’ untranslated region at the expected C-rich sequence elements. Furthermore, these mRNAs are typically involved in cancer progression and include the p53 signaling pathway that is dysregulated upon HNRNPK knockdown or K19 knockout. This study identifies how a cytoskeletal protein can directly regulate gene expression by controlling subcellular localization of RNA binding proteins to support pathways involved in cancer progression.en_US
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationFallatah, A., Anastasakis, D., Manzourolajdad, A., Sharma, P., Wang, X., Jacob, A., Alsharif, S., Elgerbi, A., Coulombe, P., Hafner, M., & Chung, B. M. (2022). HNRNPK is retained in the cytoplasm by Keratin 19 to stabilize target mRNA. biorxiv. https://doi.org/10.1101/2022.01.24.477557en_US
dc.identifier.urihttps://hdl.handle.net/1805/31616
dc.language.isoenen_US
dc.relation.isversionof10.1101/2022.01.24.477557en_US
dc.relation.journalbiorxiven_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceOtheren_US
dc.subjectKeratin 19en_US
dc.subjectHNRNPKen_US
dc.subjectP53en_US
dc.subjectbreast canceren_US
dc.titleHNRNPK is retained in the cytoplasm by Keratin 19 to stabilize target mRNAsen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Fallatah2022HNRNPK-CCBYNCND.pdf
Size:
1.28 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: